Evie Koslosky
Stock Analyst at Goldman Sachs
(0.73)
# 3,763
Out of 5,182 analysts
9
Total ratings
16.67%
Success rate
-6.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Evie Koslosky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintains: Neutral | $110 → $95 | $86.80 | +9.45% | 2 | Apr 14, 2026 | |
| DHR Danaher | Maintains: Buy | $265 → $230 | $180.62 | +27.34% | 2 | Apr 13, 2026 | |
| BRKR Bruker | Maintains: Sell | $40 → $35 | $36.53 | -4.19% | 2 | Feb 13, 2026 | |
| MTD Mettler-Toledo International | Initiates: Neutral | $1,475 | $1,274.70 | +15.71% | 1 | Dec 9, 2025 | |
| A Agilent Technologies | Initiates: Buy | $170 | $115.62 | +47.03% | 1 | Dec 9, 2025 | |
| TMO Thermo Fisher Scientific | Initiates: Buy | $685 | $468.04 | +46.36% | 1 | Dec 9, 2025 |
Revvity
Apr 14, 2026
Maintains: Neutral
Price Target: $110 → $95
Current: $86.80
Upside: +9.45%
Danaher
Apr 13, 2026
Maintains: Buy
Price Target: $265 → $230
Current: $180.62
Upside: +27.34%
Bruker
Feb 13, 2026
Maintains: Sell
Price Target: $40 → $35
Current: $36.53
Upside: -4.19%
Mettler-Toledo International
Dec 9, 2025
Initiates: Neutral
Price Target: $1,475
Current: $1,274.70
Upside: +15.71%
Agilent Technologies
Dec 9, 2025
Initiates: Buy
Price Target: $170
Current: $115.62
Upside: +47.03%
Thermo Fisher Scientific
Dec 9, 2025
Initiates: Buy
Price Target: $685
Current: $468.04
Upside: +46.36%